Dai, Wei http://orcid.org/0000-0003-1650-1590
Wang, Yaqin http://orcid.org/0000-0003-4373-7435
Liu, Yangjun http://orcid.org/0000-0002-3540-5361
Wei, Xing http://orcid.org/0000-0002-3035-5633
Osman, Ahmed M. Y. http://orcid.org/0000-0002-9068-2513
Pompili, Cecilia http://orcid.org/0000-0001-6746-5441
Koller, Michael
Wang, Qifeng http://orcid.org/0000-0001-8544-9007
Wang, Yi
Ge, Jun
Xie, Tianpeng
Li, Qiang http://orcid.org/0000-0003-1841-4132
Funding for this research was provided by:
Chengdu Science and Technology Project (2019-YF09-00234-SN)
Article History
Received: 14 May 2021
Accepted: 2 November 2021
First Online: 10 November 2021
Declarations
:
: The study protocol was approved by the Ethics Committee of Sichuan Cancer Hospital (No. SCCHEC-02-2020-066) and was registered in the Chinese Clinical Trial Registry (No. ChiCTR2000041514). Written informed consent was obtained from all study participants.
: Not applicable.
: CP and MK are members of the EORTC Quality of Life Group. All other authors declare no conflict of interests.